StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.18−0.43 (-2.44%)

Close on Nov 17, 2026Market cap $1.95BP/E –Yield –

Immunome enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Immunome's enterprise value was $1.58B on Nov 11, 2026, against $1.42B a year earlier. Over the last 5 years it ranged from -$3.95M to $2.52B, with a median of $410.00M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.58B-7.2%
2025Dec 31, 2025$1.70B+322.7%
2024Dec 31, 2024$401.55M+905.7%
2023Dec 29, 2023$39.93M–
2022Dec 30, 2022-$276.02K-100.3%
2021Dec 31, 2021$100.49M+2064.6%
2020Dec 31, 2020$4.64M–

More Immunome figures

See a number that looks wrong?